Global Health Technologies Coalition’s “Breakthroughs”: Research Roundup: A vaginal ring to prevent HIV, antibodies against Ebola, and the U.S. response to malaria
Kat Kelley, GHTC’s senior program assistant, highlights recent news in global health, including two clinical trials demonstrating that a monthly vaginal ring containing the antiretroviral drug dapivirine can reduce the risk of HIV infection in women; the identification of 300 antibodies against Ebola that could play a role in the research and development of Ebola vaccines and treatment; and President Barack Obama’s call for Congress to allocate an additional US$200 million for the President’s Malaria Initiative (2/29).